United States Ex Rel. Paulos v. Stryker Corp.
762 F.3d 688
8th Cir.2014Background
- In the early 2000s clinicians observed a spike in chondrolysis; concern focused on intra-articular "pain pumps" (Stryker, I-Flow) that deliver local anesthetic into joint spaces.
- Dr. Lonnie Paulos, an orthopedic surgeon and former Stryker consultant, filed a qui tam FCA suit alleging Stryker and I-Flow marketed pumps for joint-space use while concealing lack of FDA approval, safety testing, and known risks, thereby causing false claims for federal reimbursement.
- The FDA had granted §510(k) clearance for pain pumps for general intraoperative use but (according to Paulos) refused specific approval for orthopedic joint-space placement.
- After Paulos’s complaint was unsealed, defendants moved to dismiss under the FCA public-disclosure bar, arguing substantially the same allegations had been publicly disclosed; the district court dismissed, finding public disclosure and that Paulos was not an "original source."
- On appeal the Eighth Circuit reviewed (de novo) whether the public-disclosure bar applied and whether Paulos qualified for the original-source exception; the court affirmed dismissal.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the FCA public-disclosure bar (31 U.S.C. § 3730(e)(4)(A)) bars Paulos’s suit | Paulos: public reports are too general and do not disclose the specific fraudulent acts (misleading about FDA approval, hiding safety-testing absence, scienter) | Defendants: media, FDA, and regulatory reports publicly disclosed substantially the same allegations and transactions | Held: Public-disclosure bar applies; public materials disclosed the core allegations (lack of FDA approval, encouragement of joint use, concealment, knowledge of risk) |
| Whether Paulos is an "original source" under § 3730(e)(4)(B) via independent knowledge of device–disease link | Paulos: he was among the first to suspect/investigate the link and warned Stryker executives, providing independent knowledge | Defendants: Paulos’s alleged early knowledge did not materially add to public disclosures and his warnings did not show relevant scienter about joint-space placement | Held: Paulos is not an original source—his independent information did not materially add to the public record or meaningfully advance scienter evidence |
| Whether Paulos’s communications to Stryker established scienter material to FCA claims | Paulos: his 2005 fax/email warned Stryker about chondrolysis and implicated the pumps | Defendants: communications focused on anesthetic combinations, not pump placement; thus not probative of knowing fraud about joint-space marketing | Held: Communications were insufficient and largely irrelevant to proving Stryker’s scienter regarding joint-space marketing |
| Whether the district court erred by considering public documents outside the pleadings without converting to summary judgment | Paulos: district court should have converted to summary judgment under Rule 12(d) before considering extra-pleading materials | Defendants: public records and documents are integral, subject to judicial notice and properly considered on a public-disclosure dismissal | Held: No procedural error—the court properly considered public records integral to FCA public-disclosure analysis |
Key Cases Cited
- Mack v. Stryker Corp., 748 F.3d 845 (8th Cir. 2014) (context on chondrolysis and device clearance)
- Rodriguez v. Stryker Corp., 680 F.3d 568 (6th Cir. 2012) (issues on FDA indications of use for pumps)
- Costner v. URS Consultants, Inc., 153 F.3d 667 (8th Cir. 1998) (public-disclosure bar purpose and interpretation)
- United States ex rel. Rabushka v. Crane Co., 40 F.3d 1509 (8th Cir. 1994) (discussing qui tam/public-disclosure balance)
- In re Baycol Prods. Litig., 732 F.3d 869 (8th Cir. 2013) (FCA scienter focus)
- United States ex rel. Hixson v. Health Mgmt. Sys., Inc., 613 F.3d 1186 (8th Cir. 2010) (public-disclosure bar and whether false claim itself was disclosed)
- United States ex rel. Vigil v. Nelnet, Inc., 639 F.3d 791 (8th Cir. 2011) (distinguishing FCA liability from regulatory noncompliance)
- Hays v. Hoffman, 325 F.3d 982 (8th Cir. 2003) (FCA scope; negligence/regulatory noncompliance not central)
- Poteet v. Bahler Med., Inc., 619 F.3d 104 (1st Cir. 2010) (relevance of public disclosure of underlying fraud vs. false claim)
- Dingle v. Bioport Corp., 388 F.3d 209 (6th Cir. 2004) (public-disclosure principles)